Clin2
NCT05381103Possibly a fitRecruiting

PSMA scan to plan prostate surgery and help protect erections

Prostate Cancer

Part of Cancer, Kidney & urinary clinical trials.

This trial tests whether using a PSMA-PET scan before prostatectomy can guide surgery in a way that helps preserve sexual function. It may be most helpful if you have certain kinds of prostate cancer and want to keep erections after surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
288 people
Ages
40 years to 80 years
Study type
Interventional

Who can take part

  • You have “significant” prostate cancer based on specific biopsy results or risk category
  • Your current sexual function is good to mildly/moderately affected (IIEF-EF above 17)
  • You want to maintain erections after treatment
  • You will have (or recently had) a standard prostate MRI within about 6 months of surgery date
  • Your cancer doctor plans for you to have prostate removal surgery within 90 days of joining the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06122584Recruiting· Phase 3
PSMA PET scan for high-risk prostate cancer before surgery

This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.

Nancy
NCT06565247Recruiting· Phase 3
Comparing PET and MRI scans before prostate cancer surgery

This trial tests if a special PET scan (PSMA-PET) plus MRI is better than MRI alone at finding the full extent of high-risk prostate cancer before surgery. It aims to improve surgical planning by checking scan results against the removed prostate tissue.

Malmö
NCT04402151Recruiting· Phase 2
PSMA scan–guided targeted radiation for higher-risk prostate cancer

This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.

New York, New York
NCT04642027Recruiting· Phase 3
PSMA scan-guided salvage radiation after prostate surgery

This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.

Arnhem, Gelderland
NCT06398613Recruiting
Using PSMA PET scan before prostate cancer surgery

This trial is testing whether a special scan (PSMA PET/CT) before surgery can help doctors decide if you need to remove lymph nodes. It is for men with high-risk prostate cancer who are already planning to have robot-assisted prostate removal.

Oslo
NCT07386496Not yet recruiting
PSMA PET for prostate cancer diagnosis after unclear MRI

This trial tests if a special scan called PSMA PET can help diagnose prostate cancer in men whose MRI results are not clear. It may help avoid unnecessary biopsies.

Hong Kong

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.